BR0109946A - 6-O-Substituted Erythromycin Derivatives Having Gastrointestinal Tolerance - Google Patents

6-O-Substituted Erythromycin Derivatives Having Gastrointestinal Tolerance

Info

Publication number
BR0109946A
BR0109946A BR0109946-9A BR0109946A BR0109946A BR 0109946 A BR0109946 A BR 0109946A BR 0109946 A BR0109946 A BR 0109946A BR 0109946 A BR0109946 A BR 0109946A
Authority
BR
Brazil
Prior art keywords
erythromycin derivatives
gastrointestinal tolerance
compounds
substituted erythromycin
gastrointestinal
Prior art date
Application number
BR0109946-9A
Other languages
Portuguese (pt)
Inventor
Zhenkun Ma
Ly Tam Phan
Richard F Clark
Souming Zhang
Stevan Djuric
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BR0109946A publication Critical patent/BR0109946A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

"DERIVADOS DE ERITROMICINA SUBSTITUìDA EM 6-O TENDO TOLERâNCIA GASTROINTESTINAL". Os compostos tendo a fórmula (I) são úteis para o tratamento de infecções bacterianas, ao mesmo tempo evitando o risco concomitante de intolerância gastrointestinal. As composições contendo os compostos e os métodos de tratamento usando os compostos são também divulgados."ERYTHROMYCIN DERIVATIVES SUBSTITUTED IN 6-O HAVING GASTROINTESTINAL TOLERANCE". Compounds having formula (I) are useful for treating bacterial infections while avoiding the concomitant risk of gastrointestinal intolerance. Compositions containing the compounds and methods of treatment using the compounds are also disclosed.

BR0109946-9A 2000-10-16 2001-10-16 6-O-Substituted Erythromycin Derivatives Having Gastrointestinal Tolerance BR0109946A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24077700P 2000-10-16 2000-10-16
PCT/US2001/032278 WO2002032919A2 (en) 2000-10-16 2001-10-16 6-o-substituted erythromycin derivatives having improved gastrointestinal tolerance

Publications (1)

Publication Number Publication Date
BR0109946A true BR0109946A (en) 2005-08-02

Family

ID=22907903

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0109946-9A BR0109946A (en) 2000-10-16 2001-10-16 6-O-Substituted Erythromycin Derivatives Having Gastrointestinal Tolerance

Country Status (9)

Country Link
EP (1) EP1328534A2 (en)
JP (1) JP2004529857A (en)
AU (1) AU2002213267A1 (en)
BR (1) BR0109946A (en)
CA (1) CA2420012A1 (en)
MX (1) MXPA03003311A (en)
PE (1) PE20020522A1 (en)
UY (1) UY26964A1 (en)
WO (1) WO2002032919A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2469304A1 (en) 2001-12-05 2003-06-19 Ortho-Mcneil Pharmaceutical, Inc. 6-o acyl ketolide antibacterials
JP2005529143A (en) * 2002-04-30 2005-09-29 アボット・ラボラトリーズ Antibacterial compounds with improved pharmacokinetic profiles
US6727229B2 (en) * 2002-08-19 2004-04-27 Enanta Pharmaceuticals, Inc. 11,12-substituted lactone ketolide derivatives having antibacterial activity
WO2004078771A1 (en) * 2003-03-07 2004-09-16 Taisho Pharmaceutical Co., Ltd. 2-fluoro-6-o-substituted ketolide derivative
JP2007223900A (en) * 2004-02-03 2007-09-06 Taisho Pharmaceut Co Ltd 6-o-substituted ketolide derivative
JP2007254285A (en) * 2004-03-16 2007-10-04 Taisho Pharmaceut Co Ltd 2-fluoro-6-o-substituted ketolide derivative
WO2007091393A1 (en) 2006-02-07 2007-08-16 Taisho Pharmaceutical Co., Ltd. 10a-AZALIDE COMPOUND
US8293715B2 (en) 2007-08-06 2012-10-23 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound crosslinked at 10a- and 12-positions
JPWO2009139181A1 (en) 2008-05-15 2011-09-15 大正製薬株式会社 10a-azalide compound having a 4-membered ring structure
CN102234302B (en) * 2010-05-07 2014-05-07 北京理工大学 Novel ketolide derivatives, and preparation method and medicinal compositions thereof
AR085286A1 (en) 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd MACROLIDO DERIVATIVE REPLACED IN POSITION C-4
AR102810A1 (en) 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd MACROLID DERIVATIVE REPLACED IN POSITION C-4

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity

Also Published As

Publication number Publication date
AU2002213267A1 (en) 2002-04-29
JP2004529857A (en) 2004-09-30
EP1328534A2 (en) 2003-07-23
CA2420012A1 (en) 2002-04-25
MXPA03003311A (en) 2003-09-10
UY26964A1 (en) 2002-06-20
PE20020522A1 (en) 2002-06-25
WO2002032919A3 (en) 2002-09-19
WO2002032919A2 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
NO20075066L (en) Pharmaceutical composition containing isoflavones
NO20006323L (en) Glycopeptide derivatives and pharmaceutical compositions containing them
WO2001066564A3 (en) Gamma-secretase inhibitors
DE69720551D1 (en) MACROCYCLIC DERIVATIVES OF ERYTHROMYCIN A AND B WITH 13 RINGATOMAS
AP9801253A0 (en) 9-Oxime erythromycin derivatives.
BR0109703A (en) Piperazine Derivatives
DK1200418T3 (en) Nematodicidal trifluorobutene
TR200200579T2 (en) Amino-thyrazolpyridine derivatives.
WO2003010138A3 (en) Piperidine derivatives as antibacterial agents
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
MA25009A1 (en) PROCESS FOR THE PREPARATION OF PIPERIDINE-DERIVED COMPOUNDS FOR THE PREPARATION OF ANTIBACTERIAL COMPOSITIONS
NO20003233L (en) 4-hydroxyquinoline-3-carboxamides and hydrazides as antivirals
DK0915898T3 (en) Crystal form I of clarithromycin
AU6350699A (en) Chemical compounds
BR9811099A (en) Urokinase inhibitors
DK1499590T3 (en) Piperidine derivatives as potassium channel blockers
BR0109946A (en) 6-O-Substituted Erythromycin Derivatives Having Gastrointestinal Tolerance
CA2185512A1 (en) Treatment of Tinnitus Using Neuroprotective Agents
NO20005400L (en) Quinolones used as MRS inhibitors and bactericides
BR0010938A (en) 13-Methyl erythromycin derivatives
BR9905089A (en) Macrolide derivatives
BR0017157A (en) 6-hydroxy-indazole derivatives for the treatment of glaucoma
BR0109483A (en) Imidazopyridine Derivative Prodrugs
TR200201128T2 (en) Tetrahydrothiopyraniphalazinone derivatives as PDE4 inhibitors.
SE0003476D0 (en) Compounds

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired